Pharmaceuticals company Natco Pharma announced Q1FY26 results Consolidated total revenue of Rs 1,390.6 crore for Q1FY26 as against Rs 1,410.7 crore as Q1FY25. EBITDA for the quarter was at Rs 632.7 crore with margins at 45.5%. Net profit for the period, on a consolidated basis was Rs 480.3 crore. The Board of Directors have declared an interim dividend of Rs 2 per equity share of Rs 2 each during Q1FY26. Result PDF